Table 3.
Biomarkers statistically significantly associated with dengue haemorrhagic fever (WHO 1997 classification) but only reported in a single study.
| Study | Biomarker(s) | No. of participants |
|---|---|---|
| Cui, 201616 | Serotonin, kynurenine , phenylalanyl-tryptophan, oleamide, leucyl-phenylalanine, docosenamide, deoxyinosine, leucyl-Alanine, phenylalanylphenylalanine, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), N-heptanoylglycine, bilirubin, palmitic amide | 52 |
| Han, 201917 | Fibrinogen-like protein 1 (FGL1), microfibril-associated glycoprotein 4 (MFAP4), glutamate-ammonia ligase (GLUL), Coagulation Factor IX (F9), laminin subunit beta 2 (LAMB2), tissue type plasminogen activator (PLAT) | 36 |
| Kumar, 201222 | Serum amyloid A (SAA), histidine-phosphotransfer (HPT), platelet-derived growth factor-BB (PDGF-BB) | 34 |
| Suwarto, 201736 | Chondroitin sulfate, claudin-5 | 103 |
| Villamor, 201839 | Pentadecanoic acid, stearic acid, behenic acid, 1n-7 cis-vaccenic acid, docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), 3n-6 dihomo-γ-linolenic acid, 4n-6 arachidonic acid, 4n-6 adrenic acid, stearoyl-coA-desaturase 18, Δ5-desaturase 20 | 344 |
| Villar-Centeno, 200840 | Lactate dehydrogenase (LDH), triglyceride (TG) | 199 |
| Houghton, 201019 | Soluble suppression of tumorigenesis-2 (sST2) | 38 |
| Laur, 199824 | Transforming growth factor beta (TGF-β) | 52 |
| Yamanaka, 201345 | Complement component 2 protein (C2), complement C4-A | 112 |
| Chaiyaratana, 200814 | Ferritin | 117 |
| Conroy, 201515 | endoglin (ENG), soluble intercellular adhesion molecules (sICAMs) | 111 |